Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
T. P. Reddy(Houston Methodist), Roberto R. Rosato(MaineHealth)
Cited by 14
Related Papers
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
|Breast Cancer Research|2018|112
Gene expression of the insulin-like growth factor system during mouse kidney development
|Molecular and Cellular Endocrinology|1997|60
mRNA expression patterns of the IGF system during mouse limb bud development, determined by whole mount in situ hybridization
|Molecular and Cellular Endocrinology|1998|41